DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Naproxcinod is an investigational drug.
There have been 9 clinical trials for Naproxcinod. The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2005.
The most common disease conditions in clinical trials are Osteoarthritis, Hypertension, and Osteoarthritis, Knee. The leading clinical trial sponsors are NicOx and [disabled in preview].
Recent Clinical Trials for Naproxcinod
|Pharmacokinetics Study: Determination of Naproxcinod and Its Metabolites After Oral Administration in Male||NicOx||Phase 1|
|Effect of Repeated Dosing of Naproxcinod on Renal Hemodynamic and on Sodium Balance in Healthy Volunteers Before and After a Single Dose of Furosemide||NicOx||Phase 1|
|A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function||NicOx||Phase 1|